Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.20%
SPX
-0.64%
IXIC
-1.15%
FTSE
-0.32%
N225
-2.03%
AXJO
-0.62%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!
Stocks
Health Care
asnd
Ascendis Pharma A/S
NASDAQ: ASND
+0.29 (+0.15%)
194.19
USD
At close at Aug 29, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Ascendis Pharma A/S News

benzinga.com

How Do Investors Really Feel About Ascendis Pharma?

3 days ago
benzinga.com

Peering Into Ascendis Pharma's Recent Short Interest

about 2 months ago
benzinga.com

Is Ascendis Pharma Gaining or Losing Market Support?

3 months ago
prnewswire.com

Orsini chosen by Ascendis to distribute treatment for rare endocrine disorder in the U.S.

Feature Image for interests on Health Care & Hospitals, Healthcare, Medical Pharmaceuticals, Pharmaceuticals from prnewswire.com
9 months ago
finance.yahoo.com

Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program

Feature Image for interests on Cancer Treatments, Chief Development Officer, Clinical Development, Clinical Trials from finance.yahoo.com
11 months ago
finance.yahoo.com

High Growth Tech Stocks To Watch In October 2024

Feature Image for interests on Amicus Therapeutics, Ascendis Pharma, Biopharmaceutical Company, Earnings Growth from finance.yahoo.com
11 months ago
finance.yahoo.com

GentiBio Appoints Mark Bach, M.D., Ph.D., as Chief Medical Officer

Feature Image for interests on Andy Walker, Biopharmaceutical Companies, Chief Medical Officer, Clinical Research from finance.yahoo.com
11 months ago
finance.yahoo.com

BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish

Feature Image for interests on Achondroplasia, Alexander Hardy, Ascendis Pharma, Biomarin Pharmaceutical from finance.yahoo.com
11 months ago
finance.yahoo.com

High Growth Tech Stocks to Watch in September 2024

Feature Image for interests on Earnings Growth, Healthcare, Inc., Market Cap from finance.yahoo.com
12 months ago
finance.yahoo.com

High Growth Tech Stocks To Watch For Potential Robust Returns

Feature Image for interests on Crowdstrike, Earnings Growth, Healthcare, Revenue Growth from finance.yahoo.com
12 months ago

Latest Cashu News

publisher logo
Cashu

Ascendis Pharma A/S Sees Short Interest Decline, Suggesting Positive Market Sentiment Shift

3 days ago
publisher logo
Cashu

Ascendis Pharma A/S: Decrease in Short Interest Signals Market Optimism and Growth Potential

5 days ago
publisher logo
Cashu

Ascendis Pharma A/S Sees 20.27% Drop in Short Interest, Boosting Investor Confidence

about 2 months ago